Fasciola antigens as vaccines against fascioliasis and schistosomiasis

Journal of Helminthology

Volumn 79, Issue 3 SPEC. ISS., 2005, Pages 241-247

  Hillyer, G V ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; CYTOSOL AMINOPEPTIDASE; DNA VACCINE; FASCIOLA ANTIGEN; FATTY ACID BINDING PROTEIN; GLUTATHIONE TRANSFERASE; HEMOGLOBIN; PARASITE ANTIGEN; SAPONIN; UNCLASSIFIED DRUG; VACCINE;

AMINO ACID SEQUENCE; CONFERENCE PAPER; CROSS REACTION; FASCIOLA HEPATICA; FASCIOLIASIS; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PARASITE PREVALENCE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; VACCINATION;

ANIMALS; ANTIGENS, HELMINTH; CATHEPSINS; CROSS REACTIONS; FASCIOLA HEPATICA; FASCIOLIASIS; FATTY ACID-BINDING PROTEINS; GLUTATHIONE TRANSFERASE; HUMANS; SAPOSINS; SCHISTOSOMIASIS MANSONI; VACCINES; VACCINES, DNA;

FASCIOLA; FASCIOLA HEPATICA; SCHISTOSOMA MANSONI; TREMATODA;

EID: 23944439368     PISSN: 0022149X     EISSN: None     Source Type: Journal    
DOI: 10.1079/JOH2005304     Document Type: Conference Paper

References (53)

1. Almeida, M.S., Torloni, H., Lee-Ho, P., Vilar, M.M., Taumaturgo, N., Simpson, A.J. & Tendler, M. (2003) Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14. Parasite Immunology 25, 135-137.
2. Bjorland, J., Bryan, R.T., Strauss, W., Hillyer, G.V. & McAuley, J.B. (1995) An outbreak of acute fascioliasis among Aymara Indians in the Bolivian Altiplano. Clinical Infectious Diseases 21, 1228-1233.
3. Casanueva, P., Hillyer, G.V., Ramajo, V., Oleaga, A., Espinoza, E.Y. & Muro, A. (2001) Immunoprophylaxis against Fasciola hepatica in rabbits using a recombinant Fh15 fatty acid-binding protein. Journal of Parasitology 87, 697-700.
4. Curtale, F., Hammoud, E.S., Wakeel, A., Mas-Coma, S. & Savioli, L (2000) Human fascioliasis, an emerging public health problem in the Nile Delta, Egypt. Research and Reviews in Parasitology 60, 129-134.
5. Dalton, J.P., Brindley, P.J., Knox, D.P., Brady, C.P., Hotez, P.J., Donnelly, S., O'Neill, S.M., Mulcahy, G. & Loukas, A. (2003a) Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression. International Journal for Parasitology 33, 621-640.
6. Dalton, J.P., Neill, S.O., Stack, C., Collins, P., Walshe, A., Sekiya, M., Doyle, S., Mulcahy, G., Hoyle, D., Khaznadji, E., Moire, N., Brennan, G., Mousley, A., Kreshenko, N., Maules, A.G. & Donnely, S.M. (2003b) Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines. International Journal for Parasitology 33, 1173-1181.
7. De Bont, J., Cleerebout, E., Riveau, G., Schacht, A.M., Smets, K., Conder, G., Brake, D.A., Capron, A. & Vercruysse, J. (2003) Failure of a recombinant Schistosoma bovis-derived glutathione S-transferase to protect cattle against experimental Fasciola hepatica infection. Veterinary Parasitology 113, 135-144.
8. Espino, A.M. & Hillyer, G.V. (2001) Isolation and immunological characterization of fatty acid binding protein isoforms from Fasciola hepatica. Journal of Parasitology 87, 1028-1033.
9. Espino, A.M. & Hillyer, G.V. (2003) Molecular cloning of a member of the Fasciola hepatica saposin-like protein family. Journal of Parasitology 89, 545-552.
10. Espino, A.M. & Hillyer, G.V. (2004) A novel Fasciola hepatica saposinlike recombinant protein with immunoprophylactic potential. Journal of Parasitology 90, 876-879.
11. Espino, A.M., Gil, R., Osuna, A. & Hillyer, G.V. (2005) Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice. Experimental Parasitology in press.
12. Esteban, J.G., Bargues, M.D. & Mas-Coma, S. (1998) Geographical distribution, diagnosis and treatment of human fascioliasis: a review. Research and Reviews in Parasitology 58, 13-42.
13. Estuningsih, S.E., Smooker, P.M., Wiedosari, E., Widjajanti, S., Vaiano, S., Partoutomo, S. & Spithill, T.W. (1997) Evaluation of antigens of Fasciola gigantica as vaccines against tropical fasciolosis in cattle. International Journal for Parasitology 27, 1419-1428.
14. Harmsen, M.M., Cornelissen, J.B., Buijs, H.E., Boersma, W.J., Jeurissen, S.H. & van Milligen, F.J. (2004) Identification of a novel Fasciola hepatica cathepsin L protease containing protective epitopes within the propeptide. International Journal for Parasitology 34, 675-682.
15. Haroun, E.T.M. & Hillyer, G.V. (1986) Resistance to fascioliasis: a review. Veterinary Parasitology 20, 63-93.
16. Hien, T.V., Dung, T.T.K., Chi, N.H., Dahn, P.H. & Pham, P.T. (2001) Fascioliasis in Vietnam. South East Asian Journal of Tropical Medicine and Public Health 31 (Supplement 2), 48-50.
17. Hillyer, G.V. (1976) Can we vaccinate against schistosomes? Federation Proceedings, American Societies for Experimental Biology 35, 2568-2571.
18. Hillyer, G.V. (1979) Schistosoma mansoni: reduced worm burdens in mice immunized with isolated Fasciola hepatica antigens. Experimental Parasitology 48, 287-296.
19. Hillyer, G.V. (1984) Immunity to schistosomes using heterologous trematode antigens. Veterinary Parasitology 14, 263-283.
20. Hillyer, G.V. (1985) Induction of immunity in mice to Fasciola hepatica with a Fasciola/Schistosoma cross-reactive defined immunity antigen. American Journal of Tropical Medicine and Hygiene 34, 1127-1131.
21. Hillyer, G.V. (1987) Heterologous resistance in schistosomiasis. Memorias do Institute Oswaldo Cruz 82 (Supplement IV), 171-174.
22. Hillyer, G.V. (1995) Comparison of purified 12 kDa and recombinant 15 kDa Fasciola hepatica antigens related to a Schistosoma mansoni fatty acid binding protein. Memorias do Instituto Oswaldo Cruz 90, 249-253.
23. Hillyer, G.V., Haroun, E.T.M., Hernandez, A. & Soler de Galanes, M. (1987) Acquired resistance to Fasciola hepatica in cattle using a purified adult worm antigen. American Journal of Tropical Medicine and Hygiene 37, 363-369.
24. Hillyer, G.V., Garcia Rosa, M.I., Alicea, H. & Hernandez, A. (1988a) Successful vaccination against murine Schistosoma mansoni infection with a purified 12 kD Fasciola hepatica cross-reactive antigen. American Journal of Tropical Medicine and Hygiene 38, 103-110.
25. Hillyer, G.V., Soler de Galanes, M., Garcia Rosa, M.I. & Montealegre, F. (1988b) Acquired immunity in schistosomiasis with purified Fasciola hepatica cross-reactive antigens. Veterinary Parasitology 29, 265-280.
26. Hillyer, G.V., Soler de Galanes, M., Rodríguez-Perez, J., Bjorland, J., Silva de Lagrava, M., Ramirez Guzman, S. & Bryan, R.T. (1992) Use of FAST-ELISA and EITB to determine the prevalence of human fascioliasis in the Bolivian Altiplano. American Journal of Tropical Medicine and Hygiene 46, 603-609.
27. Hillyer, G.V. & Apt, W. (1997) Food-borne trematode infections in the Americas. Parasitology Today 13, 87-88.
28. Kofta, K.W., Mieszczanek, J., Plucienniczak, G. & Wedrychowicz, H. (2000) Successful DNA immunization of rats against fascioliasis. Vaccine 18, 2985-2990.
29. Lopez-Aban, J., Ramajo, V., Perez Arellano, J.L., Oleaga, A., Hillyer, G.V. & Muro, A. (1999) A fatty acid binding protein from Fasciola hepatica induced protection in C57/BL mice from challenge infection with Schistosoma bovis. Veterinary Parasitology 83, 107-121.
30. Lopez-Aban, J., Oleaga, A., Ramajo, V., Casanueva, P., Perez Arellano, J.L., Hillyer, G.V. & Muro, A. (2000) Vaccination of mice against Schistosoma bovis with a recombinant fatty acid binding protein from Fasciola hepatica. Veterinary Parasitology 91, 33-42.
31. Martinez-Fernandez, A.R., Nogal-Ruiz, J.J., Lopez-Aban, J., Ramajo, V., Oleaga, A., Manga-Gonzalez, Y., Hillyer, G.V. & Muro, A. (2004) Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD. Veterinary Parasitology 126, 287-298.
32. Mas-Coma, S. & Bargues, M.D. (1997) Human liver flukes: a review. Research and Reviews in Parasitology 57, 145-218.
33. Mas-Coma, S., Angles, R., Esteban, J.G., Bargues, M.D., Buchon, P., Franjen, M. & Strauss, W. (1999) The Northern Bolivian Altiplano: a region highly endemic for human fascioliasis. Tropical Medicine and International Health 4, 454-467.
34. Moghaddam, A.S., Massoud, J., Mahmoodi, M., Mahvi, A.H., Periago, M.V., Artigas, P., Fuentes, M.V., Bargues, M.D. & Mas-Coma, S. (2004) Human and animal fascioliasis in Mazandaran province, northern Iran. Parasitology Research 94, 61-69.
35. Moser, D., Tendier, M., Griffiths, G. & Klinkert, M.-Q. (1991) A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins. Journal of Biological Chemistry 266, 8447-8454.
36. Mulcahy, G. & Dalton, J.R (2001) Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants. Research in Veterinary Science 70, 83-86.
37. Mulcahy, G., O'Connor, E, McGonigle, S., Dowd, A., Clery, D.G., Andrews, S.J. & Dalton, J.P. (1998) Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica. Vaccine 16, 93-99.
38. Muro, A., Ramajo, V., Lopez, J., Simon, F. & Hillyer, G.V. (1997) Fasciola hepatica: vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins. Veterinary Parasitology 69, 219-229.
39. Paykari, H., Dalimi, A. & Madani, R. (2002) Immunization of sheep against Fasciola gigantica with glutathione S-transferase. Veterinary Parasitology 105, 153-159.
40. Piacenza, O., Acosta, D., Basmadjian, I., Dalton, J.P. & Carmona, C. (1999) Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep. Infection and Immunity 67, 1954-1961.
41. Ramajo, V., Oleaga, A., Casanueva, P., Hillyer, G.V. & Muro, A. (2001) Vaccination of sheep against Fasciola hepatica with homologous fatty acid binding proteins. Veterinary Parasitology 97, 35-46.
42. Reed, M.B., Strugnell, R.A., Pannacio, M. & Spithill, T.W. (2000) A novel member of the NK-lysin protein family is developmentally regulated and secreted by Fasciola hepatica. Moecular and Biochemical Parasitology 105, 297-303.
43. Rodriguez-Perez, J., Rodriguez-Medina, J.R., Garcia-Blanco, M.A. & Hillyer, G.V. (1992) Fasciola hepatica: molecular cloning, nucleotide sequence, and expression of a gene encoding a polypeptide homologous to a Schistosoma mansoni fatty acid-binding protein. Experimental Parasitology 74, 400-407.
44. Sirisriro, S., Grams, R., Vichasri-Grams, S., Ardseungneon, P., Pankao, V., Meepool, A., Chaithirayanon, K., Viyanant, V., Tan-Ariya, P., Upatham, E.S. & Sobhon, P. (2002) Production and characterization of a monoclonal antibody against recombinant fatty acid binding protein of Fasciola gigantica. Veterinary Parasitology 105, 119-129.
45. Smooker, P.M., Steper, K.R., Drew, D.R., Strugnell, R.A. & Spithill, T.W. (1999) Humoral responses in mice following vaccination with DNA encoding glutathione S-transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression. Parasite Immunology 321, 357-364.
46. Smooker, P.M., Kennedy, N.J., Steeper, K.R., Christopoulos, H. & Spithill, T.W. (2001) Fasciola: kinetics and quality of humoral responses to fatty acid binding protein and cathepsin L following delivery as DNA vaccines in mice. Experimental Parasitology 97, 154-160.
47. Spithill, T.W. & Dalton, J.P. (1998) Progress in the development of liver fluke vaccines. Parasitology Today 14, 224-228.
48. Spithill, T.W., Smooker, P.M. & Copeman, D.B. (1999a) Fasciola gigantica: epidemiology, control, immunology, and molecular biology, pp. 465-525 in Dalton, J.P. (Ed.) Fasciolosis. Wallingford, Oxon, CAB International.
49. Spithill, T.W., Smooker, P.M., Sexton, J.L., Bozas, E., Nirrusib, C.S., Creany, J. & Parsons, J.C. (1999b) Development of vaccines against Fasciola hepatica. pp. 377-410 in Dalton, J.P. (Ed.) Fasciolosis. Wallingford, Oxon, CAB International.
50. Tendler, M., Brito, C.A., Vilar, M.M., Serra-Freire, N., Diogo, C.M., Almeida, M.S., Delbem, A.C., Da Silva, J.F., Savino, W., Garratt, R.C., Katz, N. & Simpson, A.S. (1996) A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proceedings of the National Academy of Sciences, USA 93, 269-273.
51. Van Milligen, F.J., Cornelissen, J. & Bokhout, B. A. (2000) Fasciola hepatica: an antigen fraction derived from newly excysted juveniles, containing an immunoreactive 32-kDa protein, induces strong protective immunity in rats. Experimental Parasitology 94, 163-171.
52. Vilar, M.M., Barrientos, F., Almeida, M., Taumaturgo, N., Simpson, A., Garrat, R. & Tendler, M. (2003) An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis. Vaccine 22, 137-144.
53. Wedrychowicz, H., Lamparska, M., Kesik, M., Kotomski, G., Mieszczanek, J., Jedlina-Panasiuk, L. & Plucienniczak, A. (2003) The immune response of rats to vaccination with the cDNA or protein forms of the cysteine proteinase of Fasciola hepatica. Veterinary Immunology and Immunopathology 94, 83-93.